Stopped: study terminated due to low accrual
The purpose of this study is to determine how safe and effective fondaparinux is in treating patients with suspected or confirmed heparin-induced thrombocytopenia (HIT).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants Showing Clinically Significant Bleeding
Timeframe: 4 weeks after INR reaches 2 or more